PropThink: SGYP Advances 2nd Clinical-Stage GI Treatment; Positive for the …

PropThink: SGYP Advances 2nd Clinical-Stage GI Treatment; Positive For The …

Filed under: drug treatment news articles

Synergy Pharmaceuticals (NASDAQ:SGYP) recently submitted an IND (Investigational New Drug application) for its IBD (inflammatory bowel disease) treatment, SP-333, and is on track to meet management's objective to begin clinical trials with the compound …
Read more on Reuters

Article Says Agency Let Risky Drugs Hit Market

Filed under: drug treatment news articles

They cite an MS drug with apparent adverse effects on the heart and many other risks, and an anticoagulant linked to bleeding that is proving difficult to treat. "These examples raise the question of whether it was good policy to approve three …
Read more on Wall Street Journal

Novartis drug JakaviR first medication to receive European Commission …

Filed under: drug treatment news articles

Novartis International AG / Novartis drug JakaviR first medication to receive European Commission approval to treat patients with myelofibrosis . Processed and ….. We welcome comments on our articles for a limited period after their publication …
Read more on Reuters

More drug treatment news articles Resources

PropThink: SGYP Advances 2nd Clinical-Stage GI Treatment; Positive For The Stock
Synergy Pharmaceuticals (NASDAQ:SGYP) recently submitted an IND (Investigational New Drug application) for its IBD (inflammatory bowel disease) treatment, SP-333, and is on track to meet management`s objective … Read News